ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (0LIF)

64.79
0.00
(0.00%)
Closed 29 June 1:30AM

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 540.63M490.75M719.56M1.14B1.76B1.52B1.55B1.49B
Total Current Assets 401.7M269.58M522.37M851.02M1.3B856.6M883.9M732.18M
Cash and Equivalents 161.12M100.49M113.43M433.58M713.53M307.58M132.94M213.58M
Total Non-Current Assets 473.97M383.45M608.91M653.76M1.15B922.56M352.49M275.41M
Total Liabilities 66.65M107.3M110.65M481.73M605.18M599.84M1.19B1.22B
Total Current Liabilities 60.26M71.01M74.73M103.3M189.61M181.37M261.21M280.44M
Total Non-Current Liabilities 6.39M36.29M35.93M378.43M751.94M770.66M1.81B1.8B
Total Equity 473.97M383.45M608.91M653.76M1.15B922.56M352.49M275.41M
Common Equity 41k44k51k58k67k69k70k82k
Retained Earnings -530.53M-832.67M-1.03B-1.43B-1.62B-2.07B-2.78B-3.39B